Summary:
Evaluate the Safety, Tolerability and Efficacy of investigational drug in Subjects with Irritable Bowel Syndrome (IBS-C or IBS-D) Experiencing Abdominal Pain who are not on concomitant treatment for IBS.
Qualified Participants Must:
• Male or Female ages 18-70
•
Clinical diagnosis of IBS-C or IBS